Showing results (271-280 of 4,755) with videos related to
Sort By:
Pageof 476
Current Gastroenterology Reports|March 30, 2011
Growth assessment in clinical practice: whose growth curve?Howard G Parsons, Michael A George, Sheila M InnisCancer|June 1, 1978
A correlation of serum C3DP levels with chemotherapeutic management of cancer patientsR G Parsons, J A Hoch, R L LongmireNeuropharmacology|May 1, 1995
Different binding affinities of NMDA receptor channel blockers in various brain regions--indication of NMDA receptor heterogeneityI Bresink, W Danysz, C G Parsons, et al.Pigment Cell Research|February 1, 1993
In vivo and in vitro expression of octamer binding proteins in human melanoma metastases, brain tissue, and fibroblastsJ A Thomson, P G Parsons, R A SturmFrontiers in Behavioral Neuroscience|August 27, 2010
Regulation of extinction-related plasticity by opioid receptors in the ventrolateral periaqueductal gray matterRyan G Parsons, Georgette M Gafford, Fred J HelmstetterPain|March 29, 2001
Mrz 2/579, a fast kinetic NMDA channel blocker, reduces the development of morphine tolerance in awake ratsAndrea K Houghton, Chris G Parsons, Max P HeadleyMelanoma Research|December 1, 1994
Alteration of tyrosinase activity in human melanocytes and melanoma cells by histamine H2 and H3 ligandsG Le Gros, X M Zhang, P G ParsonsProstaglandins|August 1, 1989
Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acidJ D Morrow, W G Parsons, L J RobertsBiochemical Pharmacology|November 15, 1986
Selective toxicity of deoxyadenosine analogues in human melanoma cell linesP G Parsons, E P Bowman, R L BlakleyLearning & Memory (Cold Spring Harbor, N.Y.)|December 3, 2005
Effects of post-training hippocampal injections of midazolam on fear conditioningGeorgette M Gafford, Ryan G Parsons, Fred J HelmstetterPageof 476